Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DT6QP4
|
|||
| Drug Name |
BNT165
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Malaria [ICD-11: 1F40-1F45; ICD-9: 84] | Phase 1 | [1] | |
| Company |
BioNTech
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05581641) An Exploratory Phase I, Randomized, Observer-blind, Placebo-controlled Dose Escalation Trial Evaluating the Safety, Tolerability and Immunogenicity of an Investigational RNA-based Vaccine for Active Immunization Against Malaria. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.